In contrast, the women who developed SGA without preeclampsia, (n = 57) or indeed women who developed preeclampsia without SGA (n = 32) displayed no significant changes in circulating syndecan-1 (Fig. 1E,F) relative to controls. The gene discussed is SDC1; the disease is preeclampsia.